Skip to main content
Top
Published in: Supportive Care in Cancer 7/2016

01-07-2016 | Original Article

The association of psychosocial screening and service provision in pediatric oncology: the Psychosocial Assessment Tool (PAT2.0) into clinical practice

Authors: M. C. McCarthy, S. DeGraves, C. E. Wakefield, M. J. Bowden, L. V. Marks, L. K. Williams

Published in: Supportive Care in Cancer | Issue 7/2016

Login to get access

Abstract

Purpose

Distress screening in oncology has been widely endorsed in recent years. However, current knowledge of the impact of screening on delivery of clinical psychosocial services is limited. This study investigated the association between screening and psychosocial services in the early period following diagnosis of childhood cancer.

Methods

The Psychosocial Assessment Tool (PAT2.0) was administered by clinical social workers in two pediatric oncology centers shortly following diagnosis. Psychosocial service activity in the first 8 weeks post diagnosis was collected via social work surveys and extraction of information from hospital databases.

Results

PAT2.0 and psychosocial service data were obtained for 89 families with a child newly diagnosed with cancer. Distribution of PAT2.0 risk categories was consistent with previous studies (57.3 % universal, 38.2 % targeted, 4.5 % clinical). Significant, weak to moderate correlations between PAT2.0 and social workers’ estimates of psychosocial risk were observed. No significant differences in the amount of psychosocial services provided to families with “universal” versus “elevated” (i.e., targeted or clinical) risk were found. Number of days in hospital was strongly and positively associated with the amount of psychosocial services families received in the first 8 weeks following diagnosis.

Conclusions

Psychosocial risk, as measured by the PAT2.0, and allocation of psychosocial services were not significantly associated in the early period following diagnosis. Further investigation is required to understand if differences emerge over time when psychosocial screening is implemented clinically. Development of clinical pathways of care needs to account for patients who may predominantly be treated in the outpatient setting.
Literature
2.
go back to reference Lazenby M (2014) The international endorsement of US distress screening and psychosocial Guidelines in oncology: a model for dissemination. J Natl Compr Cancer Netw 221–227 Lazenby M (2014) The international endorsement of US distress screening and psychosocial Guidelines in oncology: a model for dissemination. J Natl Compr Cancer Netw 221–227
5.
go back to reference Comission for Cancer (2012) Cancer program standards 2012: ensuring patient centred care, V1.0. American College of Surgeons, Chicago Comission for Cancer (2012) Cancer program standards 2012: ensuring patient centred care, V1.0. American College of Surgeons, Chicago
7.
go back to reference Pai AL, Patino-Fernandez AM, McSherry M, Beele D, Alderfer MA, Reilly AT, Hwang WT, Kazak AE (2008) The Psychosocial Assessment Tool (PAT2.0): psychometric properties of a screener for psychosocial distress in families of children newly diagnosed with cancer. J Pediatr Psychol 33(1):50–62. doi:10.1093/jpepsy/jsm053 Pai AL, Patino-Fernandez AM, McSherry M, Beele D, Alderfer MA, Reilly AT, Hwang WT, Kazak AE (2008) The Psychosocial Assessment Tool (PAT2.0): psychometric properties of a screener for psychosocial distress in families of children newly diagnosed with cancer. J Pediatr Psychol 33(1):50–62. doi:10.​1093/​jpepsy/​jsm053
9.
go back to reference Kazak AE, Schneider S, Didonato S, Pai ALH (2015) Family psychosocial risk screening guided by the pediatric psychosocial preventative health model (PPPHM) using the Psychosocial Assessment Tool (PAT). Acta Oncol 54(5):574–580. doi:10.3109/0284186X.2014.995774 CrossRefPubMed Kazak AE, Schneider S, Didonato S, Pai ALH (2015) Family psychosocial risk screening guided by the pediatric psychosocial preventative health model (PPPHM) using the Psychosocial Assessment Tool (PAT). Acta Oncol 54(5):574–580. doi:10.​3109/​0284186X.​2014.​995774 CrossRefPubMed
10.
go back to reference McCarthy M, Clarke N, Vance A, Ashley D, Heath J, Anderson V (2009) Measuring psychosocial risk in families caring for a child with cancer: the Psychosocial Assessment Tool (PAT2.0). Pediatr Blood Cancer 5:78–83. doi:10.1002/pbc.22007 CrossRef McCarthy M, Clarke N, Vance A, Ashley D, Heath J, Anderson V (2009) Measuring psychosocial risk in families caring for a child with cancer: the Psychosocial Assessment Tool (PAT2.0). Pediatr Blood Cancer 5:78–83. doi:10.​1002/​pbc.​22007 CrossRef
11.
go back to reference Barrera M, Hancock K, Rokeach A, Cataudella D, Atenafu E, Johnston D, Punnett A, Nathan PC, Bartels U, Silva M, Cassidy M, Jansen P, Shama W, Greenberg C (2014) External validity and reliability of the Psychosocial Assessment Tool (PAT) among Canadian parents of children newly diagnosed with cancer. Pediatr Blood Cancer 61(1):165–170. doi:10.1002/pbc.24774 CrossRefPubMed Barrera M, Hancock K, Rokeach A, Cataudella D, Atenafu E, Johnston D, Punnett A, Nathan PC, Bartels U, Silva M, Cassidy M, Jansen P, Shama W, Greenberg C (2014) External validity and reliability of the Psychosocial Assessment Tool (PAT) among Canadian parents of children newly diagnosed with cancer. Pediatr Blood Cancer 61(1):165–170. doi:10.​1002/​pbc.​24774 CrossRefPubMed
12.
go back to reference Alderfer MA, Mougianis I, Barakat LP, Beele D, DiTaranto S, Hwang WT, Reilly AT, Kazak AE (2009) Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool. Cancer 115(18 Suppl):4339–4349. doi:10.1002/cncr.24587 CrossRefPubMed Alderfer MA, Mougianis I, Barakat LP, Beele D, DiTaranto S, Hwang WT, Reilly AT, Kazak AE (2009) Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool. Cancer 115(18 Suppl):4339–4349. doi:10.​1002/​cncr.​24587 CrossRefPubMed
13.
go back to reference Kazak AE, Barakat LP, Hwang WT, Ditaranto S, Biros D, Beele D, Kersun L, Hocking MC, Reilly A (2011) Association of psychosocial risk screening in pediatric cancer with psychosocial services provided. Psycho-Oncology 20(7):715–723. doi:10.1002/pon.1972 CrossRefPubMed Kazak AE, Barakat LP, Hwang WT, Ditaranto S, Biros D, Beele D, Kersun L, Hocking MC, Reilly A (2011) Association of psychosocial risk screening in pediatric cancer with psychosocial services provided. Psycho-Oncology 20(7):715–723. doi:10.​1002/​pon.​1972 CrossRefPubMed
14.
go back to reference Barrera M, Hancock K, Rokeach A, Atenafu E, Cataudella D, Punnett A, Johnston D, Cassidy M, Zelcer S, Silva M, Jansen P, Bartels U, Nathan P, Greenbery C (2014) Does the use of the revised Psychosocial Assessment Tool (PATrev) result in improved quality of life and reduced psychosocial risk in Canadian families with a child newly diagnosed with cancer? Psycho-Oncology 23(2):165–172. doi:10.1002/pon.3386 CrossRefPubMed Barrera M, Hancock K, Rokeach A, Atenafu E, Cataudella D, Punnett A, Johnston D, Cassidy M, Zelcer S, Silva M, Jansen P, Bartels U, Nathan P, Greenbery C (2014) Does the use of the revised Psychosocial Assessment Tool (PATrev) result in improved quality of life and reduced psychosocial risk in Canadian families with a child newly diagnosed with cancer? Psycho-Oncology 23(2):165–172. doi:10.​1002/​pon.​3386 CrossRefPubMed
15.
go back to reference Kazak A, Cant M, Jensen MM, McSherry M, Rourke M, Hwang W, Alderfer M, Beele D, Simms S, Lange B (2003) Identifying psychosocial risk indicative of subsequent resource use in families of newly diagnosed paediatric oncology patients. J Clin Oncol 21(17):3220–3225CrossRefPubMed Kazak A, Cant M, Jensen MM, McSherry M, Rourke M, Hwang W, Alderfer M, Beele D, Simms S, Lange B (2003) Identifying psychosocial risk indicative of subsequent resource use in families of newly diagnosed paediatric oncology patients. J Clin Oncol 21(17):3220–3225CrossRefPubMed
17.
go back to reference Karlson C, Leist-Haynes S, Smith M, Faith M, Elkin T, Megason G (2012) Examination of risk and resiliency in a pediatric sickle cell disease population using the Psychosocial Assessment Tool 2.0. J Pediatr Psychol 37(9):51–56. doi:10.1093/jpepsy/jss087 CrossRef Karlson C, Leist-Haynes S, Smith M, Faith M, Elkin T, Megason G (2012) Examination of risk and resiliency in a pediatric sickle cell disease population using the Psychosocial Assessment Tool 2.0. J Pediatr Psychol 37(9):51–56. doi:10.​1093/​jpepsy/​jss087 CrossRef
18.
go back to reference Pai AL, Tackett A, Hente E, Ernest M, Denson L, Hommel K (2014) Assessing psychosocial risk in pediatric inflammatory bowel disease: validation of the Psychosocial Assessment Tool 2.0_general. J Pediatr Gastroentrerol Nutr 58(1):51–56. doi:10.1097/MPG.0b013e3182a938b7 Pai AL, Tackett A, Hente E, Ernest M, Denson L, Hommel K (2014) Assessing psychosocial risk in pediatric inflammatory bowel disease: validation of the Psychosocial Assessment Tool 2.0_general. J Pediatr Gastroentrerol Nutr 58(1):51–56. doi:10.​1097/​MPG.​0b013e3182a938b7​
Metadata
Title
The association of psychosocial screening and service provision in pediatric oncology: the Psychosocial Assessment Tool (PAT2.0) into clinical practice
Authors
M. C. McCarthy
S. DeGraves
C. E. Wakefield
M. J. Bowden
L. V. Marks
L. K. Williams
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3107-4

Other articles of this Issue 7/2016

Supportive Care in Cancer 7/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine